Novavax and Canada Reach Agreement in Principle to Acquire Novavax’ COVID-19 Vaccine
• Canadian government to purchase up to 76 million doses of NVX-CoV2373 GAITHERSBURG, Md., Aug. 31, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it has reached an agreement in principle with the Government of Canada to supply up to 76 million […]